| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/07/2003 | WO2003064699A2 Apparatus for synthesis of arrays of dna probes |
| 08/07/2003 | WO2003064698A1 Electrophoretic assay to predict risk of cancer and the efficacy and toxicity of cancer therapy |
| 08/07/2003 | WO2003064696A2 Methods for reducing contamination by genetically modified plant products |
| 08/07/2003 | WO2003064695A1 Nucleic acid fragments for the identification of dechlorinating bacteria |
| 08/07/2003 | WO2003064694A1 Method for operating a computer and/or computer network to distribute biotechnology products |
| 08/07/2003 | WO2003064693A1 Mart-1 compounds for therapy and diagnosis and methods for using same |
| 08/07/2003 | WO2003064692A1 Detecting and quantifying many target nucleic acids within a single sample |
| 08/07/2003 | WO2003064691A2 Methods and means for amplifying nucleic acid |
| 08/07/2003 | WO2003064690A2 Process for detecting predisposition to a cardiovascular disease |
| 08/07/2003 | WO2003064689A2 Methods for identifying polyadenylation sites and genes thereof |
| 08/07/2003 | WO2003064688A2 Method of generation and management of unique sequences in dna production |
| 08/07/2003 | WO2003064687A2 Prognostic and treatment methods relating to fibrotic liver disease |
| 08/07/2003 | WO2003064686A1 Method and test kit for demonstrating genetic identity |
| 08/07/2003 | WO2003064685A2 Genetic polymorphisms in the preprotachykinin gene |
| 08/07/2003 | WO2003064684A1 Method of quantifying cholesterol in high density lipoprotein and reagent compositions |
| 08/07/2003 | WO2003064683A1 Method of quantifying glycosylated protein using redox reaction and quantification kit |
| 08/07/2003 | WO2003064682A1 Cancer monitoring by aberrant promotor methylation of the transcription factor genes pax5 alpha pax5 beta, novel loop helix loop protein, novel gene 2, and beta3 genes |
| 08/07/2003 | WO2003064681A2 Assays |
| 08/07/2003 | WO2003064679A2 Methods for detecting vancomycin-resistant microorganisms and compositions therefor |
| 08/07/2003 | WO2003064676A2 Diagnostic and therapeutic methods using the h37 tumor suppressor gene |
| 08/07/2003 | WO2003064675A2 Rapid methods and devices for the detection of coliform and the detection and confirmation of e. coli |
| 08/07/2003 | WO2003064670A1 Single-tube, ready-to-use assay kits and methods using same |
| 08/07/2003 | WO2003064665A2 Viral vector |
| 08/07/2003 | WO2003064663A1 Polymorphisms in elastin, fibrillin, and related genes as predisposing to restenosis and to atherosclerosis |
| 08/07/2003 | WO2003064657A1 A rapid and sensitive assay for the detection and quantification of coregulators of nucleic acid binding factors |
| 08/07/2003 | WO2003064645A1 Novel n-acetylgalactosamine transferase and nucleic acid encoding the same |
| 08/07/2003 | WO2003064629A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 08/07/2003 | WO2003064628A2 Novel proteins and nucleic acids encoding same |
| 08/07/2003 | WO2003064624A2 Molecular hepatotoxicology modeling |
| 08/07/2003 | WO2003064622A2 Aggrecanase molecules |
| 08/07/2003 | WO2003064615A2 Amplifying repetitive nucleic acid sequences |
| 08/07/2003 | WO2003064613A2 Amidases, nucleic acids encoding them and methods for making and using them |
| 08/07/2003 | WO2003064605A2 Crude biological derivatives competent for nucleic acid detection |
| 08/07/2003 | WO2003064604A2 Translation profiling |
| 08/07/2003 | WO2003064600A2 The il-1 gene cluster and associated inflammatory polymorphisms and haplotypes |
| 08/07/2003 | WO2003064599A2 Cancer genes |
| 08/07/2003 | WO2003064593A2 Antigen panels and methods of using the same |
| 08/07/2003 | WO2003064588A2 Structural basis of quorum sensing signal generation and methods and therapeutic agents derived therefrom |
| 08/07/2003 | WO2003064471A2 Gene for peripheral arterial occlusive disease |
| 08/07/2003 | WO2003064469A2 Regulation of human hematopoietin receptor-like protein |
| 08/07/2003 | WO2003064468A2 The ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3), its crystal structure, and uses thereof |
| 08/07/2003 | WO2003064466A1 Variants of the alpha 1 subunit of human ampk |
| 08/07/2003 | WO2003064465A2 Prkag3 gene promoter and uses thereof |
| 08/07/2003 | WO2003064463A2 Pluripotency determining factors and uses thereof |
| 08/07/2003 | WO2003064451A2 MODULATION OF TYPE IIβ PHOSPHOINOSITIDE PHOSPHATE KINASE |
| 08/07/2003 | WO2003064448A2 Degp protease: cleavage site identification and proteolysis of a natural target in e. coli |
| 08/07/2003 | WO2003064441A2 Oligonucleotides comprising alternating segments and uses thereof |
| 08/07/2003 | WO2003063907A1 Drugs ameliorating circadian rhythum disorder |
| 08/07/2003 | WO2003063893A2 Fgfr agonists |
| 08/07/2003 | WO2003063798A2 Compositions and methods for treatment of infectious and inflammatory diseases |
| 08/07/2003 | WO2003063783A2 Multiple virus replicon culture systems |
| 08/07/2003 | WO2003063773A2 Differentially-regulated prostate cancer genes |
| 08/07/2003 | WO2003063766A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 08/07/2003 | WO2003063765A2 Multi-disciplinary approach to validating or identifying targets using an in vivo system |
| 08/07/2003 | WO2003063693A2 Method for detecting microorganisms |
| 08/07/2003 | WO2003063689A2 Islr gene and its association with osteoarthritis and other bone and cartilage disorders, expression products derived therefrom, and uses thereof |
| 08/07/2003 | WO2003063678A2 Streptococcus agalactiae in vitro diagnostic |
| 08/07/2003 | WO2003044223A3 Phosphine-containing formulations for chemiluminescent luciferase assays |
| 08/07/2003 | WO2003042366A3 A novel saitohin gene and uses of same |
| 08/07/2003 | WO2003040340A9 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer |
| 08/07/2003 | WO2003035834A3 Compositions and methods for making mutations in cell lines and animals |
| 08/07/2003 | WO2003030826A3 Antisense modulation of insulin-like growth factor binding protein 5 expression |
| 08/07/2003 | WO2003030616A3 21132, a human g-protein coupled receptor family member and uses therefor |
| 08/07/2003 | WO2003020911A9 Human schizophrenia gene |
| 08/07/2003 | WO2003014695A3 Biosensor and method for detecting macromolecular biopolymers by means of at least one unit for immobilizing macromolecular biopolymers |
| 08/07/2003 | WO2003012447A3 Identification of living microorganisms, eukaryotic cells or organelles |
| 08/07/2003 | WO2003008640A3 Asthma-associated gene |
| 08/07/2003 | WO2003000919B1 Method for detecting diseases caused by chromosomal imbalances |
| 08/07/2003 | WO2002092825B1 Retroviral vectors for gene therapy |
| 08/07/2003 | WO2002084285A3 Gradient resolved hybridisation platform |
| 08/07/2003 | WO2002066642A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 08/07/2003 | WO2002061114A9 Water-soluble, fluorescent and mobile peptide substrates |
| 08/07/2003 | WO2002059611A3 Diagnosis and treatment of cancer using mammalian pellino polypeptides and polynucleotides |
| 08/07/2003 | WO2002059363A3 Method for detecting of prions in a sample |
| 08/07/2003 | WO2002059360A3 Ammonium sulfate for neutralization of inhibitory effects |
| 08/07/2003 | WO2002059359A3 Method for non-redundant library construction |
| 08/07/2003 | WO2002057783A3 Method of screening for gpr40 ligands |
| 08/07/2003 | WO2002050288A9 Neocentromere-based mini-chromosomes or artificial chromosomes |
| 08/07/2003 | WO2002050274A3 Seleno-cysteine containing protein zsel1 |
| 08/07/2003 | WO2002046386A3 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase |
| 08/07/2003 | WO2002045659A9 Novel therapeutics for heart failure and aging |
| 08/07/2003 | WO2002033119A3 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 08/07/2003 | WO2002031204A3 Assay to detect integration of a retrovirus polynucleotide into a target nucleic acid |
| 08/07/2003 | WO2002027036A3 Probes, probe sets, methods and kits pertaining to the detection, identification and/or enumeration of bacteria |
| 08/07/2003 | WO2002027025A3 Application of bioinformatics for direct study of unculturable microorganisms |
| 08/07/2003 | WO2002020850A3 Novel prkag3 alleles and use of the same as genetic markers for reproductive and meat quality traits |
| 08/07/2003 | WO2002020848A3 Gene and sequence variation associated with cancer |
| 08/07/2003 | WO2002020826A3 An electronic database of enzyme substrate and enzyme inhibitor structures |
| 08/07/2003 | WO2002018608A9 Methods for enhancing the efficacy of cancer therapy |
| 08/07/2003 | WO2002016650A3 Compositions and methods for exon profiling |
| 08/07/2003 | WO2002012563A3 Detection and diagnosis of smoking related cancers |
| 08/07/2003 | WO2002008381A3 Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia |
| 08/07/2003 | WO2002004681A3 Method of detection by enhancement of silver staining |
| 08/07/2003 | WO2002004678A3 Methods and compositions for diagnosing and treating preeclampsia and gestational trophoblast disorders |
| 08/07/2003 | WO2002004122B1 Improved stability of hybridisation interactions in dipstick assays |
| 08/07/2003 | WO2002002225A9 Single molecule sequencing method |
| 08/07/2003 | WO2001092578A3 Reagents and methods for identifying and modulating expression of genes regulated by retinoids |
| 08/07/2003 | WO2001090417A3 Materials and methods for detection of nucleic acids |
| 08/07/2003 | WO2001090400A3 Methods for monitoring production of gene products and uses thereof |
| 08/07/2003 | WO2001075176A3 Methods and systems for molecular fingerprinting |